v3.25.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   75,367,117      
Beginning balance at Dec. 31, 2023 $ 200,810 $ 7 $ 1,327,881 $ (1,456) $ (1,125,622)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share based compensation 19,035   19,035    
Issuance of common stock under the equity incentive plan and proceeds from exercise (in shares)   849,945      
Issuance of common stock under the equity incentive plan and proceeds from exercise 0 $ 1 (1)    
Employee stock purchase program purchase and expense (in shares)   239,500      
Employee stock purchase program purchase and expense 1,950   1,950    
Foreign currency translation adjustments 1,033     1,033  
Unrealized loss on marketable debt securities (1,211)     (1,211)  
Net loss (206,470)       (206,470)
Ending balance (in shares) at Jun. 30, 2024   76,456,562      
Ending balance at Jun. 30, 2024 15,147 $ 8 1,348,865 (1,634) (1,332,092)
Beginning balance (in shares) at Mar. 31, 2024   76,108,829      
Beginning balance at Mar. 31, 2024 74,071 $ 8 1,337,638 (1,892) (1,261,683)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share based compensation 9,615   9,615    
Issuance of common stock under the equity incentive plan and proceeds from exercise (in shares)   108,233      
Employee stock purchase program purchase and expense (in shares)   239,500      
Employee stock purchase program purchase and expense 1,612   1,612    
Foreign currency translation adjustments 404     404  
Unrealized loss on marketable debt securities (146)     (146)  
Net loss (70,409)       (70,409)
Ending balance (in shares) at Jun. 30, 2024   76,456,562      
Ending balance at Jun. 30, 2024 15,147 $ 8 1,348,865 (1,634) (1,332,092)
Beginning balance (in shares) at Dec. 31, 2024   87,452,835      
Beginning balance at Dec. 31, 2024 59,077 $ 9 1,506,315 (80) (1,447,167)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share based compensation $ 21,509   21,509    
Issuance of common stock under the equity incentive plan and proceeds from exercise (in shares) 1,434,200 1,529,161      
Issuance of common stock under the equity incentive plan and proceeds from exercise $ 4,706   4,706    
Employee stock purchase program purchase and expense (in shares)   120,351      
Employee stock purchase program purchase and expense 2,168   2,168    
Foreign currency translation adjustments (418)     (418)  
Unrealized loss on marketable debt securities (314)     (314)  
Net loss (53,981)       (53,981)
Ending balance (in shares) at Jun. 30, 2025   89,102,347      
Ending balance at Jun. 30, 2025 32,747 $ 9 1,534,698 (812) (1,501,148)
Beginning balance (in shares) at Mar. 31, 2025   88,787,429      
Beginning balance at Mar. 31, 2025 32,823 $ 9 1,522,050 (843) (1,488,393)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share based compensation 10,331   10,331    
Issuance of common stock under the equity incentive plan and proceeds from exercise (in shares)   194,567      
Issuance of common stock under the equity incentive plan and proceeds from exercise 463   463    
Employee stock purchase program purchase and expense (in shares)   120,351      
Employee stock purchase program purchase and expense 1,854   1,854    
Foreign currency translation adjustments 268     268  
Unrealized loss on marketable debt securities (237)     (237)  
Net loss (12,755)       (12,755)
Ending balance (in shares) at Jun. 30, 2025   89,102,347      
Ending balance at Jun. 30, 2025 $ 32,747 $ 9 $ 1,534,698 $ (812) $ (1,501,148)